Marsh and Health In Tech Compared in Head-to-Head Analysis

Analysts see more upside potential in Health In Tech stock compared to Marsh

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Marsh (NYSE:MRSH) and Health In Tech (NASDAQ:HIT) are both financial services companies, but a comparison of the two shows Health In Tech may be the stronger investment. Analysts have a higher price target and more favorable consensus rating for Health In Tech, which also trades at a higher valuation than Marsh. However, Marsh has higher revenue and earnings, as well as stronger institutional ownership.

Why it matters

This analysis provides investors with a detailed comparison of two financial services companies, highlighting the relative strengths and weaknesses of each stock. It can help inform investment decisions between the two firms.

The details

The analysis compares Marsh and Health In Tech across several key metrics, including valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. While Marsh has higher revenue and earnings, Health In Tech is seen as having more upside potential based on analyst price targets and consensus ratings.

  • The analysis was published on February 13, 2026.

The players

Marsh

A professional services company that provides advice and solutions in the areas of risk, strategy, and people worldwide.

Health In Tech

A company that engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the relative strengths and weaknesses of two financial services companies, Marsh and Health In Tech. While Marsh has higher revenue and earnings, Health In Tech is seen as having more upside potential by analysts. Investors should consider these factors when evaluating the two stocks.